eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis has the capability to solve the global organ crisis by providing an alternative to allotransplantation. eGenesis is uniquely positioned to reinvigorate the field of xenotransplantation by addressing both the key virology and immunology hurdles that have impeded its advancement to date and provide commercially-viable products to save and enhance the lives of patients in need.

GreenLight Biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its patented Cell free bioprocessing technology platform. This revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control.